Ranolazine-d3 is the deuterium labeled version of Ranolazine, an anti-angina agent that inhibits the late phase of inward sodium current (INa) and IKr, with IC50 values of 6 μM and 12 μM, respectively, without impacting heart rate or blood pressure. It also acts as a partial fatty acid oxidation (FAO) inhibitor. This compound is an antianginal agent primarily used for research purposes. Deuteration can affect the pharmacokinetic and metabolic profiles of drugs.
- Used as a tracer
- Functions as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS